Context Therapeutics Inc
F:6K9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Context Therapeutics Inc
F:6K9
|
US |
|
B
|
Barrick Gold Corp
DUS:ABR
|
CA |
|
A
|
Alnylam Pharmaceuticals Inc
F:DUL
|
US |
|
U
|
UniCredit SpA
WSE:UCG
|
IT |
|
C
|
ConvaTec Group PLC
SWB:2CV
|
UK |
|
Woolworths Holdings Ltd
F:WN3
|
ZA |
|
S
|
Swiss Re AG
SWB:SR9A
|
CH |
|
R
|
Renault SA
DUS:RNL
|
FR |
|
M
|
Melco Resorts & Entertainment Ltd
F:MAS
|
HK |
|
Eagle Materials Inc
F:E5M
|
US |
|
C
|
Cooper Companies Inc
XBER:CP6
|
US |
|
E
|
Expeditors International of Washington Inc
XHAM:EW1
|
US |
|
A
|
Addus Homecare Corp
F:A41
|
US |
|
V
|
Vodafone Group PLC
DUS:VODJ
|
UK |
Bankruptcy Probability
Context Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Context Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Context Therapeutics Inc
NASDAQ:CNTX
|
218.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
532.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Context Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Context Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
